Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes
- PMID: 36658631
- PMCID: PMC9850788
- DOI: 10.1186/s13027-023-00480-4
Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes
Erratum in
-
Correction: Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes.Infect Agent Cancer. 2023 Feb 2;18(1):6. doi: 10.1186/s13027-023-00484-0. Infect Agent Cancer. 2023. PMID: 36732833 Free PMC article. No abstract available.
Abstract
The role of gut microbiota and its products in human health and disease is profoundly investigated. The communication between gut microbiota and the host involves a complicated network of signaling pathways via biologically active molecules generated by intestinal microbiota. Some of these molecules could be assembled within nanoparticles known as outer membrane vesicles (OMVs). Recent studies propose that OMVs play a critical role in shaping immune responses, including homeostasis and acute inflammatory responses. Moreover, these OMVs have an immense capacity to be applied in medical research, such as OMV-based vaccines and drug delivery. This review presents a comprehensive overview of emerging knowledge about biogenesis, the role, and application of these bacterial-derived OMVs, including OMV-based vaccines, OMV adjuvants characteristics, OMV vehicles (in conjugated vaccines), cancer immunotherapy, and drug carriers and delivery systems. Moreover, we also highlight the significance of the potential role of these OMVs in diagnosis and therapy.
Keywords: Adjuvant; Biomarker; Drug delivery; Microbiota; Outer membrane vesicle; Vaccine.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
